The Development Grant, awarded to Dr Wise (Chief Investigator B), Associate Professor Martin Ng (Chief Investigator A, Royal Prince Alfred Hospital), and Dr Raj Makkar (Chief Investigator C, Cedars-Sinai Medical Center) in partnership with Sydney-based start-up Endoluminal Sciences, will support work to commercially develop their sealant technology, making a safer and more effective heart valve treatment available to the thousands who need it every year.
The NHMRC Development Grants scheme supports the commercial development of a research outcome that, if applied, would result in improved health care, disease prevention or provide health cost savings. Only 20 NHMRC Development Grants have been awarded across Australia this year, and only three in NSW.